levonorgestrel has been researched along with Hypomenorrhea in 145 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (21.38) | 18.7374 |
| 1990's | 56 (38.62) | 18.2507 |
| 2000's | 31 (21.38) | 29.6817 |
| 2010's | 21 (14.48) | 24.3611 |
| 2020's | 6 (4.14) | 2.80 |
| Authors | Studies |
|---|---|
| Holopainen, E; Luiro, K | 1 |
| Bailón-Queiruga, M; Calaf-Alsina, J; Estadella-Tarriel, J; Gich-Saladich, I; Llurba-Olivé, E; Perelló-Capó, J | 1 |
| Alves, RDMS; Andrade, VR; Brito, MB; Cabral, RCS; Merriman, JW; Rabelo, MM | 1 |
| Fernandes, A; Juliato, C; Monteiro, I; Wittmann, BZ | 1 |
| But, A; Gissler, M; Gyllenberg, FK; Heikinheimo, O; Laine, MK; Saloranta, TH | 1 |
| Ahlers, C; Beckert, V; Frenz, AK; Friede, T; Gerlinger, C | 1 |
| Faundes, A; Juliato, C; Miranda, L; Sousa, MH | 1 |
| Al-Halaby, A; Emarh, M; Rezk, M; Shawky, M | 1 |
| Bahamondes, L; Carvalho, NM; Chou, V; Garcia, EAL; Margatho, D; Modesto, W | 1 |
| Blumenthal, PD; Creinin, MD; Keder, LM; Olariu, AI; Schreiber, CA; Teal, SB | 1 |
| Nisihara, R; Sgarbi, F; Wandresen, G | 1 |
| Chen, YY; Lan, KC; Ou, YC; Tsai, CC | 1 |
| Bayer, LL; Hillard, PJ | 1 |
| Akintomide, H; Brima, N; Copas, A; O'Brien, P; Panicker, S; Sauer, U; Shawe, J; Stephenson, J; Wilkinson, C | 1 |
| Abdel-Aleem, H; d'Arcangues, C; Gaffield, ML; Gülmezoglu, AM; Vogelsong, KM | 2 |
| Kostev, K; Rashed, AN; Ziller, M; Ziller, V | 1 |
| Halpern, V; Lopez, LM; Raymond, EG | 1 |
| Rome, ES; Strandjord, SE | 1 |
| Dempster-Rivett, K; Smalldridge, J | 1 |
| Bunkheila, A; China, S; Powell, M; Robinson, R | 1 |
| Chaudhari, A; Peterson, CM; Rose, S | 1 |
| Aisien, AO; Enosolease, ME | 1 |
| Dorflinger, L; Hubacher, D; Lopez, L; Steiner, MJ | 1 |
| Ahrendt, HJ; Makalová, D; Mansour, D; Mellinger, U; Parke, S | 1 |
| Hill, E; O'Brien, K; Pillai, M | 1 |
| Andrade, A; Wildemeersch, D | 1 |
| Cremer, M; Jacobs, A; Phan-Weston, S | 1 |
| Hillman, JB; Inge, TH; Miller, RJ | 1 |
| Haoula, ZJ; Powell, MC; Walker, KF | 1 |
| Grimes, DA; Helmerhorst, FM; Lopez, LM; Schulz, KF; Van Vliet, HA | 2 |
| Firdous, N; Rana, M; Saxena, P | 1 |
| Prema, K | 1 |
| Abdalla, MI; Fayad, MM; Ibrahim, II; Shafeek, MA | 1 |
| Arshat, H | 1 |
| Zhu, YH | 1 |
| Haspels, AA; Van Santen, MR | 1 |
| Belaisch, J | 1 |
| Ratnam, SS; Singh, K; Viegas, OA | 1 |
| Abed, A; Chelli, H; Habibi, H; Khrouf, M; Messaad, J; Ouerghemmi, R; Rouis, M; Sfar, E; Zouari, F | 2 |
| Chen, CH; Du, MK; Zheng, HM | 1 |
| London, RS | 1 |
| Valle, G | 1 |
| Lopez, G; Rodriguiz, A | 1 |
| Porter, C; Rees, MC | 1 |
| Lowles, IE; Macnab, JL | 1 |
| Rivera, R; Rountree, W | 1 |
| Eizenberg, DH | 1 |
| Wu, SC; Xiao, BL | 1 |
| Emembolu, JO; Konje, JC; Lockhat, FB | 1 |
| Bigrigg, A; Gallagher, J; Hesketh, C; Loftus-Granberg, B; Shochet, T; Tyrer, A; Webb, A | 1 |
| Radesic, B; Sharma, A | 1 |
| Möller, B; Odlind, V; Olovsson, M; Rönnerdag, M; Wang, G | 1 |
| Aisien, AO; Enosolease, ME; Shobowale, MO | 1 |
| Mirando, S | 1 |
| Grimes, DA; Helmerhorst, FM; Schulz, KF; Van Vliet, HA | 1 |
| Raymond, E | 1 |
| Abdel-Aleem, H; d'Arcangues, C; Gülmezoglu, AM; Vogelsong, K | 1 |
| Beliard, A; Blacher, S; Foidart, JM; Frankenne, F; Fridman, V; Labied, S; Munaut, C; Nisolle, M; Stéphanie, R | 1 |
| Abdel-Aleem, H; d'Arcangues, C; Gülmezoglu, AM; Vogelsong, KM | 1 |
| Archer, DF; Jensen, JT | 1 |
| Cersosimo, L; Consalvo, F; Iannucci, D; Orgiu, G | 1 |
| Coutinho, E; Diaz, S; Holma, P; McDonald, O; Robertson, DN; Sanchez, FA; Sivin, I; Stern, J | 1 |
| Salah, M; Shaaban, MM | 1 |
| Ahren, T; Akinla, O; Alvarez-Sanchez, F; Brache, V; Brenner, PF; Coutinho, E; Darze, E; Diaz, J; Diaz, S; Fasan, MO; Faundes, A; Gama daSilva, JC; Giwa-Osagie, OF; Jackanicz, TM; Mishell, DR; Nash, HA; Nielsen, NC; Pavez, M; Pyorala, T; Roy, S; Sivin, I; Stern, J; Victor, A; Zausner-Guelman, B | 2 |
| Kuusi, T; Nikkilä, EA; Sipinen, S; Tikkanen, MJ | 1 |
| Noerpramana, NP | 2 |
| Datey, S; Gaur, LN; Saxena, BN | 1 |
| Bardin, CW | 1 |
| Chi, IC; Farr, G | 1 |
| Habib, ND; Joachim, A; Kato, K; Nielsen, P | 1 |
| van Amerongen, D | 1 |
| Affandi, B; Au, CL; Rogers, PA | 1 |
| Coutinho, EM; Ladipo, O | 1 |
| Bachmann, GA; Knuppel, RA; Owens, AG; Pasquale, SA | 1 |
| Du, MK; Gu, SJ; Liu, YL; Sivin, I; Wang, SH; Zhang, LD | 1 |
| Akhter, H; Amatya, RN; Begum, K; Chowdhury, T; Dighe, N; Dunson, TR; Krueger, SL; Rahman, S | 1 |
| Croxatto, HB | 1 |
| Gu, SJ; Shi, SQ; Wang, SL; Xiao, BL; Zhu, PD | 1 |
| Chi, IC | 1 |
| Chuang, SM; Ko, TM; Lee, TY; Tseng, LH; Yang, YS | 1 |
| Cushman, LF; Davidson, AR; Heartwell, S; Kalmuss, D; Rulin, M | 1 |
| Boulehia, N; Derbel, S; Gorgob, K; Gueddana, N; Hamzaoui, R; M'hamdi, A; Mansour, H | 1 |
| Biswas, A; Leong, WP; Ratnam, SS; Viegas, OA | 1 |
| Amatya, RN; Balogh, S; Bhatta, A; Chetri, M; Dunson, TR; Lama, H; McMahan, JH; Spivey, S | 1 |
| Amatya, RN; Dunson, TR; Krueger, SL | 1 |
| Anant, MP; Campodonico, I; Diaz, S; el din Abdalla, K; Holma, P; Kiriwat, O; Koetsawang, S; Pavez, M; Sivin, I; Stern, J; Viegas, O; Wan, L | 1 |
| Berenson, AB; McCombs, SL; Rickerr, VI; Wiemann, CM | 1 |
| Coleman, M; Farquhar, C; McCowan, L | 1 |
| Ratnam, SS; Singh, K | 1 |
| Alami, MH; Alaoui, MT; Bennani, I; Berrada, N; Chraibi, C; Hajoui, S; Khachani, M; Nabil, S | 1 |
| Ba Gueye, M; Diadhiou, F; Israël, A; Moreau, JC; Sangaré, M; Sokal, D | 1 |
| Critchley, HO; Gebbie, AE; Glasier, AF; Kelly, RW; Wang, H | 1 |
| Buckley, CH; Critchley, HO; Drudy, TA; Gebbie, AE; Glasier, AF; Jones, RL; Kelly, RW; McNeilly, AS; Wang, H | 1 |
| Bonane, B; Dao, B; Kabore, I; Kone, B; Lankoande, J; Millogo, B; Ouattara, T; Ouedraogo, A; Ouedraogo, CM; Toure, B | 1 |
| Chompootaweep, S; Dusitsin, N; Kochagarn, E; Tang-Usaha, J; Theppitaksak, B | 1 |
| Alvarez, F; Brache, V; Darney, P; Klaisle, C; Lacarra, M; Mishell, DR; Sivin, I; Stern, J; Wan, L | 1 |
| Affandi, B | 1 |
| Costa, MM; da Silva, MO | 1 |
| Odlind, V; Rönnerdag, M | 1 |
| Ba, MG; Dao, B; Diadhiou, F; Dunson, R; Kouedou, D; Moreau, JC; Sokal, D | 1 |
| Chen, CH; Chow, LP; Du, MK; Zheng, HM | 1 |
| Campbell-Heider, N; Glantz, JC; Glantz, S; Schaff, E | 1 |
| Chaudhary, I; Inayatullah, A; Rehan, N | 1 |
| Cowan, FM; French, RS; Guillebaud, J; Higgins, JP; Mansour, D; Morris, S; Procter, T; Robinson, A | 1 |
| Kaewrudee, S; Taneepanichskul, S | 1 |
| Jukarainen, H; Lähteenmäki, P | 1 |
| Tissot, B; Vekemans, M | 1 |
| He, CH; Shi, YE; Van Look, PF; Xu, JQ | 1 |
| Alvarez, F; Brache, V; Coutinho, E; Diaz, S; el Mahgoub, S; Mattos, CE; Pavez, M; Sivin, I; Stern, J; Thevenin, F | 1 |
| Barlow, DH; Rees, MC | 1 |
| Bopp, BL; Fielding, M; Mishell, DR; Shoupe, D | 1 |
| Elder, MG; Elstein, M; Lawson, JP; Nuttall, ID | 1 |
| Aznar Ramos, R; Lara Ricalde, R; Lozano Baldera, M; Reynoso Ron, L | 1 |
| Chen, HC; Chow, LP; Du, MK; Zheng, HM | 1 |
| Allonen, H; Gao, J; Luukkainen, T; Sun, BL; Wang, SL; Wu, SC | 1 |
| Baveja, R; Bichille, LK; Coyaji, KJ; Engineer, AD; Gogoi, MP; Hazra, MN; Kochhar, M; Lahiri, BC; Manuel, M; Nanda, UK | 1 |
| Apelo, R; Osteria, T; Ramos, R; Vilar, E | 1 |
| Balogh, S; Fakeye, O | 1 |
| Fraser, IS | 1 |
| Belsey, EM | 1 |
| Datey, S; Hingorani, V; Jalnawala, SF; Kochhar, M; Mehta, S; Rai Chaudhury, G; Roy, M; Saxena, BN; Saxena, NC; Sengupta, PC | 1 |
| Lopez, G; Rengifo, J; Rodriguez, A; Sivin, I | 1 |
| Gao, J; Ma, LY; Song, GY; Sun, HZ | 1 |
| Dhaliwal, LK; Gulati, K; Gupta, AN | 1 |
| Gu, SJ; Weng, LJ | 1 |
| Abo-Eloyoun, M; Ahmed, AG; Salah, M; Shaaban, MM | 1 |
| de Castro, AM; de Castro, ML; Giovanini, ME; Gomes, FM; Koifman, S; Mota, LG; Oliveira, DP; Paes, SJ; Poyares, JA; Vianna, NF | 1 |
| Liew, D; Ratnam, SS; Singh, K; Singh, P; Viegas, OA | 1 |
| Du, MG; Gao, YL; Gu, SJ; Liu, YL; Wang, PZ; Wang, SH; Wu, SL; Xu, MF; Yuan, DY; Zhang, LD | 1 |
| Chaudhury, N; Gupta, AN; Hazra, MN; Hingorani, V; Kochhar, M; Kodkany, BS; Logambal, A; Nanda, UK; Rai Choudhary, G; Raja Ram, P | 1 |
| Casado, ME; Croxatto, HB; Díaz, S; Herreros, C; Juez, G; Miranda, P; Peralta, O; Salvatierra, AM | 1 |
25 review(s) available for levonorgestrel and Hypomenorrhea
| Article | Year |
|---|---|
Management of contraceptives and menstrual complaints in patients with Down syndrome.
Topics: Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Down Syndrome; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; Progesterone; Transdermal Patch | 2019 |
Use of levonorgestrel intrauterine system for medical indications in adolescents.
Topics: Adolescent; Contraceptives, Oral, Synthetic; Female; Genital Diseases, Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances | 2013 |
Treatment of vaginal bleeding irregularities induced by progestin only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; Progestins; Randomized Controlled Trials as Topic | 2013 |
Treatment of vaginal bleeding irregularities induced by progestin only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; Progestins; Randomized Controlled Trials as Topic | 2013 |
Repeated use of pre- and postcoital hormonal contraception for prevention of pregnancy.
Topics: Coitus; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Menstruation Disturbances; Randomized Controlled Trials as Topic | 2014 |
Monthly Periods--Are They Necessary?
Topics: Adolescent; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation; Menstruation Disturbances; Periodicity; Progestins; Transdermal Patch | 2015 |
Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
Topics: Administration, Intravaginal; Contraception; Contraceptive Agents, Female; Drug Administration Schedule; Drug Delivery Systems; Female; Genital Diseases, Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Patient Satisfaction | 2009 |
Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Medication Adherence; Medroxyprogesterone Acetate; Menstruation Disturbances | 2009 |
Review of clinical experience with the frameless LNG-IUS for contraception and treatment of heavy menstrual bleeding.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Middle Aged; Pregnancy; Uterine Perforation | 2010 |
Recent innovations in oral contraception.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage | 2010 |
Triphasic versus monophasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norethindrone; Patient Compliance; Randomized Controlled Trials as Topic | 2011 |
Bleeding problems and progestogen-only contraception.
Topics: Administration, Oral; Contraceptive Agents, Female; Counseling; Desogestrel; Drug Implants; Endometrium; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Levonorgestrel; Menstruation Disturbances; Progesterone Congeners | 2002 |
Biphasic versus triphasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Norethindrone; Randomized Controlled Trials as Topic | 2006 |
Triphasic versus monophasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norethindrone; Patient Compliance; Randomized Controlled Trials as Topic | 2006 |
Treatment of vaginal bleeding irregularities induced by progestin only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; Progestins; Randomized Controlled Trials as Topic | 2007 |
Treatment of vaginal bleeding irregularities induced by progestin only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; Progestins; Randomized Controlled Trials as Topic | 2007 |
Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol for contraception and control of menstrual symptoms.
Topics: Animals; Chemistry, Pharmaceutical; Contraceptive Agents, Female; Delayed-Action Preparations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Metrorrhagia | 2008 |
The non-contraceptive effects of the levonorgestrel-releasing intrauterine device.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic | 1994 |
NORPLANT: levonorgestrel-releasing contraceptive implant.
Topics: Body Weight; Drug Implants; Female; Forearm; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Pregnancy | 1993 |
NORPLANT and the levonorgestrel IUD in Chinese family planning programmes.
Topics: Amenorrhea; China; Drug Implants; Family Planning Policy; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pregnancy | 1993 |
The TCu-380A (AG), MLCu375, and Nova-T IUDs and the IUD daily releasing 20 micrograms levonorgestrel--four pillars of IUD contraception for the nineties and beyond?
Topics: Evaluation Studies as Topic; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Uterine Perforation | 1993 |
The levonorgestrel-releasing intrauterine device: a wider role than contraception.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menstruation Disturbances; Uterine Neoplasms | 1997 |
An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Desogestrel; Dysmenorrhea; Female; Hemoglobins; Humans; Levonorgestrel; Longitudinal Studies; Medical Records; Menstruation Disturbances; Patient Dropouts; Progesterone Congeners; Randomized Controlled Trials as Topic; Vinyl Compounds | 1998 |
Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives.
Topics: Contraception; Contraceptive Agents, Female; Counseling; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Risk Factors | 2000 |
Novel delivery systems in contraception.
Topics: Adult; Contraceptive Agents; Contraceptive Agents, Male; Delayed-Action Preparations; Drug Delivery Systems; Female; Humans; Intrauterine Devices, Medicated; Iron; Levonorgestrel; Male; Menstruation Disturbances; Patient Satisfaction; Progesterone | 2000 |
37 trial(s) available for levonorgestrel and Hypomenorrhea
| Article | Year |
|---|---|
Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm
Topics: Adult; Contraceptive Agents, Female; Copper; Dysmenorrhea; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Menstruation Disturbances | 2023 |
Bleeding patterns for the Liletta
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Middle Aged; Parity; Pregnancy; Prospective Studies; Time Factors; Young Adult | 2018 |
Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill on continuation rates at 1 year.
Topics: Adolescent; Adult; Contraception Behavior; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Intention to Treat Analysis; Levonorgestrel; Lost to Follow-Up; Medication Adherence; Menstruation; Menstruation Disturbances; Middle Aged; Patient Satisfaction; Precision Medicine; Severity of Illness Index; United Kingdom; Young Adult | 2013 |
Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Metrorrhagia; Middle Aged; Nandrolone; Patient Satisfaction; Treatment Outcome; Young Adult | 2009 |
Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia.
Topics: Aged; Anticarcinogenic Agents; Biopsy; Drug Delivery Systems; Drug Monitoring; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Middle Aged; Progestins; Remission Induction | 2011 |
[Development of serial clinical study on mifepristone used as contraception].
Topics: Adult; Contraception; Contraceptives, Oral; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Mifepristone; Pregnancy; Pregnancy Rate | 2003 |
Effect of hormonal emergency contraception on bleeding patterns.
Topics: Contraceptives, Postcoital, Hormonal; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Interviews as Topic; Levonorgestrel; Menstruation; Menstruation Disturbances; Norethindrone; Pregnancy; Pregnancy, Unwanted; Safe Sex; Time Factors; Treatment Outcome | 2004 |
Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
Topics: Actins; Adult; Biopsy; Contraceptive Agents, Female; Endometrium; Female; Humans; Levonorgestrel; Menstruation Disturbances; Neovascularization, Pathologic; Prospective Studies; Stromal Cells; Time Factors; von Willebrand Factor | 2007 |
Three-year experience with NORPLANT subdermal contraception.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Drug Implants; Female; Hemoglobins; Humans; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Norgestrel; Norgestrienone; Pain; Patient Dropouts; Pregnancy | 1983 |
The non-contraceptive effects of the levonorgestrel-releasing intrauterine device.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic | 1994 |
Irregular bleeding, body mass index and coital frequency in Norplant contraceptive users.
Topics: Adult; Body Mass Index; Body Weight; Coitus; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Prospective Studies | 1994 |
A 5-year evaluation of NORPLANT contraceptive implants in China.
Topics: Adult; China; Contraceptive Agents, Female; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation Disturbances; Pregnancy; Prospective Studies; Thrombocytopenia | 1994 |
A five-year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors.
Topics: Adolescent; Adult; Bangladesh; Drug Implants; Educational Status; Female; Humans; Levonorgestrel; Menstruation Disturbances; Pregnancy; Surveys and Questionnaires | 1993 |
Phase III clinical trial with Norplant II (two covered rods): report on five years of use.
Topics: Adolescent; Adult; Body Weight; Drug Implants; Family Characteristics; Female; Follow-Up Studies; Foreign-Body Migration; Humans; Infections; Levonorgestrel; Menstruation Disturbances; Patient Dropouts; Patient Satisfaction; Pregnancy | 1993 |
Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with Norplant implants as controls.
Topics: Adolescent; Adult; Analysis of Variance; Capsules; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Finland; Humans; Incidence; Levonorgestrel; Menstruation Disturbances; Pregnancy; Pregnancy Rate; Singapore; Thailand; United States | 1997 |
Blood-lipid fractions: the side-effects and continuation of Norplant use.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Cholesterol; Confidence Intervals; Contraceptive Agents, Female; Drug Implants; Female; Humans; Indonesia; Intrauterine Devices; Levonorgestrel; Linear Models; Lipids; Lipoproteins, HDL; Menstruation Disturbances; Pain; Patient Acceptance of Health Care; Progesterone Congeners; Prospective Studies; Risk; Sample Size; Survival Analysis; Time Factors; Triglycerides | 1997 |
[Contraception by subcutaneous Norplant implants. 300 cases].
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Prurigo; Senegal | 1998 |
Experience of Thai women in Bangkok with Norplant-2 implants.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Educational Status; Female; Humans; Levonorgestrel; Menstruation Disturbances; Middle Aged; Patient Satisfaction; Pregnancy; Socioeconomic Factors; Thailand | 1998 |
Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic.
Topics: Adolescent; Adult; Analysis of Variance; Chi-Square Distribution; Contraceptive Agents, Female; Dominican Republic; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Pregnancy; United States | 1998 |
A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Collaborative Study Group on the Desogestrel-containing Progest
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Female; Humans; Levonorgestrel; Menstruation Disturbances; Middle Aged; Patient Satisfaction; Pregnancy; Progesterone Congeners; Safety; Time Factors | 1998 |
Reason, myths and fantasies: preliminary data and reflections about the Portuguese experience with LNG-IUS-induced hypomenorrhea.
Topics: Adult; Amenorrhea; Attitude to Health; Contraceptive Agents, Female; Cultural Characteristics; Drug Delivery Systems; Female; Ferritins; Hemoglobins; Humans; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Pilot Projects; Portugal; Premenopause; Social Class | 1999 |
Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
Topics: Adult; Contraceptive Agents, Female; Drug Monitoring; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Patient Acceptance of Health Care; Pelvic Inflammatory Disease; Postmenopause; Pregnancy; Regression Analysis | 1999 |
A 5-year clinical evaluation of Norplant implants in Senegal.
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Patient Satisfaction; Pregnancy; Prospective Studies; Senegal | 1999 |
A multicenter clinical study on two types of levonorgestrel tablets administered for postcoital contraception.
Topics: Adult; Body Temperature; China; Coitus; Contraceptives, Postcoital, Hormonal; Double-Blind Method; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Tablets; Time Factors | 1991 |
Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.
Topics: Adolescent; Adult; Endometriosis; Female; Hemoglobins; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menstruation Disturbances; Patient Dropouts; Pelvic Inflammatory Disease | 1991 |
The efficacy and acceptability of a low-dose levonorgestrel intravaginal ring for contraception in a UK cohort.
Topics: Adolescent; Adult; Cohort Studies; Dose-Response Relationship, Drug; Female; Fertility; Humans; International Cooperation; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Norgestrel; United Kingdom; World Health Organization | 1991 |
[Levonorgestrel releasing subcutaneous implants. 1st year's experience].
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Headache; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pain; Patient Acceptance of Health Care | 1991 |
Study of Norplant implants in Shanghai: three-year experience.
Topics: Adult; China; Contraceptive Agents, Female; Drug Evaluation; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Thrombocytopenia; Time Factors | 1990 |
Comparison of the clinical performance, contraceptive efficacy and acceptability of levonorgestrel-releasing IUD and Norplant-2 implants in China.
Topics: Administration, Intravaginal; Adult; alpha 1-Antitrypsin; Antithrombin III; China; Drug Implants; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Menstruation Disturbances; Norgestrel; Plasminogen | 1990 |
Randomized clinical trial with intrauterine devices (levonorgestrel intrauterine device (LNG), CuT 380Ag, CuT 220C and CuT 200B). A 36-month study. Indian Council of Medical Research Task Force on IUD.
Topics: Adolescent; Adult; Female; Humans; Infections; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy; Uterine Perforation | 1989 |
A comparative analysis of three different dose combinations of oral contraceptives.
Topics: Adult; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Menstruation Disturbances; Nausea; Norethindrone; Norgestrel; Patient Compliance; Philippines; Pregnancy | 1989 |
The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraceptive Agents; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Menstruation Disturbances; Norgestrel; Patient Compliance; Patient Dropouts | 1988 |
Phase II randomized comparative clinical trial of Norplant (six capsules) with Norplant-2 (two covered rods) subdermal implants for long-term contraception: report of a 24-month study. National Programme of Research in Human Reproduction.
Topics: Adolescent; Adult; Amenorrhea; Clinical Trials as Topic; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Oligomenorrhea; Random Allocation; Time Factors | 1986 |
Two-year prospective study in Colombia of Norplant implants.
Topics: Adolescent; Adult; Clinical Trials as Topic; Colombia; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Norgestrel; Pregnancy; Prospective Studies; Stereoisomerism | 1986 |
Clinical investigation of a low-dose levonorgestrel-releasing vaginal ring.
Topics: Adult; China; Clinical Trials as Topic; Contraception; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pessaries | 1986 |
Clinical performance with contraceptive vaginal rings containing levonorgestrel.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Patient Acceptance of Health Care; Patient Dropouts; Pregnancy | 1986 |
Fertility regulation in nursing women: VII. Influence of NORPLANT levonorgestrel implants upon lactation and infant growth.
Topics: Adolescent; Adult; Breast Feeding; Child Development; Clinical Trials as Topic; Drug Implants; Female; Humans; Infant; Infant, Newborn; Lactation; Levonorgestrel; Male; Menstruation Disturbances; Milk, Human; Norgestrel; Pregnancy | 1985 |
84 other study(ies) available for levonorgestrel and Hypomenorrhea
| Article | Year |
|---|---|
Heavy Menstrual Bleeding in Adolescent: Normal or a Sign of an Underlying Disease?
Topics: Adolescent; Female; Humans; Levonorgestrel; Menorrhagia; Menstruation; Menstruation Disturbances; Ovary | 2022 |
The influence of the levonorgestrel-releasing intrauterine system position on bleeding patterns in reproductive age women.
Topics: Adult; Case-Control Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Prospective Studies; Young Adult | 2019 |
Consecutive Use of the 52 mg Levonorgestrel-releasing Intrauterine System: Variations in Bleeding Patterns.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medical Audit; Menstruation; Menstruation Disturbances; Retrospective Studies; Young Adult | 2020 |
Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
Topics: Abortion, Induced; Adolescent; Adult; Age Factors; Cohort Studies; Contraceptive Agents, Female; Device Removal; Drug Implants; Educational Status; Female; Financing, Government; Finland; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Long-Acting Reversible Contraception; Marital Status; Menstruation Disturbances; Parity; Retrospective Studies; Smoking; Social Class; Young Adult | 2020 |
Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Long-Acting Reversible Contraception; Menstruation; Menstruation Disturbances; Metrorrhagia; Predictive Value of Tests | 2021 |
Continuation Rates of the 52-mg Levonorgestrel-releasing Intrauterine System according to the Primary Reason for its Use.
Topics: Adult; Brazil; Contraceptive Agents, Hormonal; Counseling; Educational Status; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Marital Status; Menstruation Disturbances; Parity; Patient Education as Topic; Regression Analysis; Retrospective Studies; Young Adult | 2021 |
Correlation between uterine artery Doppler indices and menstrual irregularities among levonorgestrel releasing intrauterine system and depot medroxyprogesterone acetate users: a prospective observational study.
Topics: Adult; Contraceptive Agents, Female; Egypt; Female; Hemodynamics; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Prospective Studies; Schools, Medical; Ultrasonography, Doppler; Uterine Artery; Young Adult | 2017 |
Relationship between user satisfaction with the levonorgestrel-releasing intrauterine system and bleeding patterns.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Middle Aged; Patient Satisfaction; Young Adult | 2017 |
Preliminary report on the use of a levonorgestrel intrauterine system for the treatment of intermenstrual bleeding due to previous cesarean delivery scar defect.
Topics: Adult; Cesarean Section; Cicatrix; Contraceptive Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Middle Aged; Postoperative Complications; Retrospective Studies | 2019 |
The prescribing of contraceptives for adolescents in German gynecologic practices in 2007 and 2011: a retrospective database analysis.
Topics: Adolescent; Androstenes; Child; Chlormadinone Acetate; Contraceptive Agents; Desogestrel; Drug Prescriptions; Drug Utilization; Female; Germany; Gynecology; Humans; Levonorgestrel; Menstruation Disturbances; Practice Patterns, Physicians'; Pregnancy; Pregnancy in Adolescence; Retrospective Studies | 2013 |
Management of menstrual difficulties in adolescents with physical and intellectual disabilities at a New Zealand tertiary hospital.
Topics: Adolescent; Cohort Studies; Disabled Persons; Female; Humans; Intellectual Disability; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; New Zealand; Retrospective Studies; Tertiary Care Centers | 2016 |
Mirena intrauterine system in the treatment of menstrual disorders: a survey of UK patients' experience, acceptability and satisfaction.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Middle Aged; Patient Satisfaction; Retrospective Studies; Surveys and Questionnaires; United Kingdom | 2008 |
Haemostatic function in Norplant (levonorgestrel) users: a 3-year prospective experience in Benin-City, Nigeria.
Topics: Adult; Contraceptive Agents, Female; Female; Hematocrit; Hemostasis; Humans; Levonorgestrel; Menstruation Disturbances; Nigeria; Partial Thromboplastin Time; Prospective Studies; Prothrombin Time | 2009 |
Intrauterine devices: an effective alternative to oral hormonal contraception.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Anticoagulants; Breast Neoplasms; Chlamydia Infections; Contraception; Contraceptives, Oral, Combined; Dysmenorrhea; Endocarditis; Epilepsy; Female; Heart Valve Diseases; Humans; Infections; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Pelvic Infection; Pregnancy; Pregnancy Complications; Pregnancy, Ectopic; Uterine Perforation | 2009 |
The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities.
Topics: Administration, Intravaginal; Adolescent; Caregivers; Child; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Disabled Persons; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menarche; Menstruation Disturbances; Patient Satisfaction; Quality of Life; Third-Party Consent; Young Adult | 2010 |
Menstrual concerns and intrauterine contraception among adolescent bariatric surgery patients.
Topics: Adolescent; Bariatric Surgery; Cohort Studies; Contraception; Contraceptive Agents, Female; Databases, Factual; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Obesity; Ohio; Patient Acceptance of Health Care; Young Adult | 2011 |
Comparison of levonorgestrel and copper releasing intrauterine contraceptive device on body iron stores and menstrual bleeding patterns: experience on Indian women.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Female; Ferritins; Hemoglobins; Humans; India; Intrauterine Devices, Copper; Iron; Levonorgestrel; Menstruation; Menstruation Disturbances; Time Factors; Young Adult | 2012 |
Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
Topics: Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormones; Injections; Intrauterine Devices; Lactation; Levonorgestrel; Menstrual Cycle; Menstruation; Menstruation Disturbances; Norethindrone; Physiology; Pregnancy; Progesterone; Progestins; Reproduction; Signs and Symptoms | 1982 |
Subdermal levonorgestrel implants and pituitary function.
Topics: Age Factors; Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endocrine System; Family Planning Services; Follicle Stimulating Hormone; Gonadotropins; Gonadotropins, Pituitary; Hormones; Levonorgestrel; Luteinizing Hormone; Menstruation; Menstruation Disturbances; Parity; Physiology; Pituitary Gland; Pituitary Hormones; Prolactin; Reproduction; Reproductive Control Agents | 1983 |
A comparative study of Loestrin versus Nordette in Kelantan, West Malaysia.
Topics: Asia; Asia, Southeastern; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Data Collection; Developing Countries; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormones; Levonorgestrel; Malaysia; Menstruation Disturbances; Metrorrhagia; Norethindrone; Patient Acceptance of Health Care; Physiology; Research; Sampling Studies; Signs and Symptoms; Statistics as Topic | 1984 |
[The efficacy of postcoital oral levonorgestrel administration in the peri-ovulatory phase of menstrual cycle].
Topics: Age Factors; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Postcoital; Disease; Economics; Endocrine System; Family Planning Services; Hormones; Levonorgestrel; Menstruation Disturbances; Physiology; Population; Population Characteristics; Reproductive Control Agents; Research; Technology | 1986 |
Post coital contraception.
Topics: Biology; Birth Rate; Breast; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Developed Countries; Digestive System; Disease; Embryo Implantation; Embryonic Development; Endocrine System; Ethics; Ethinyl Estradiol; Europe; Family Planning Services; Fertility; Hormones; Infections; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Nausea; Netherlands; Parity; Pelvic Inflammatory Disease; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Pregnancy, Ectopic; Reproduction; Signs and Symptoms; Vomiting | 1986 |
[The triphasic pill].
Topics: Biology; Blood; Blood Coagulation; Blood Pressure; Carbohydrates; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Disease; Endometrium; Estradiol; Estrogens; Family Planning Services; Genitalia; Genitalia, Female; Glucose; Hormones; Levonorgestrel; Lipids; Menstruation Disturbances; Metabolism; Norethindrone; Physiology; Reproductive Control Agents; Urogenital System; Uterus | 1985 |
Intracervical device may be effective hormonal contraceptive.
Topics: Biology; Birth Rate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Demography; Developed Countries; Diagnosis; Disease; Economics; Endocrine System; Europe; Family Planning Services; Fertility; Finland; Genitalia, Female; Hormones; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Physiology; Population; Population Dynamics; Pregnancy Rate; Reproductive Control Agents; Research; Research Design; Scandinavian and Nordic Countries; Technology; Urogenital System | 1988 |
Menstrual changes during Norplant use and return of fertility following Norplant implant removal: the Singapore experience.
Topics: Asia; Asia, Southeastern; Biology; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Disease; Family Planning Services; Follow-Up Studies; Levonorgestrel; Menstruation Disturbances; Patient Acceptance of Health Care; Physiology; Research; Singapore | 1991 |
Depo-Provera and Norplant implants prove no competition for no. 1 choice, OCs. The 1994 pill survey.
Topics: Ambulatory Care Facilities; Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Counseling; Delivery of Health Care; Developed Countries; Disease; Family Planning Services; Health; Health Personnel; Health Planning; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; North America; Therapeutics; United States | 1994 |
[Norplant contraception at the Rabta Tunis maternity hospital].
Topics: Africa; Africa, Northern; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Diabetes Mellitus; Disease; Family Planning Services; Heart Diseases; Hypertension; Lactation; Levonorgestrel; Menstruation Disturbances; Middle East; Physiology; Pregnancy; Prospective Studies; Research; Risk Factors; Tunisia; Vascular Diseases | 1994 |
An analysis of vaginal bleeding patterns in users of Norplant implants.
Topics: Asia; Asia, Eastern; China; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Disease; Family Planning Services; Levonorgestrel; Menstruation Disturbances; Prevalence; Prospective Studies; Research; Research Design | 1998 |
A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
Topics: Americas; Biology; Breast Neoplasms; Canada; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Family Planning Services; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; Metabolism; Neoplasms; North America; Patient Acceptance of Health Care; Physiology; Research | 1993 |
New contraceptive launched.
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Europe; Family Planning Services; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Scandinavian and Nordic Countries; United Kingdom | 1995 |
[The problem of postcoital contraception using oral progestins].
Topics: Blood Coagulation; Breast; Chile; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Postcoital; Disease; Evaluation Studies as Topic; Family Planning Services; Levonorgestrel; Liver; Menstruation Disturbances; Peru; Pregnancy, Unwanted; Research | 1975 |
Prospective experience with a levonorgestrel implant--Norplant.
Topics: Age Factors; Amenorrhea; Americas; Anthropometry; Behavior; Biology; Body Weight; Colombia; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Demography; Developed Countries; Developing Countries; Diagnosis; Disease; Dysmenorrhea; Educational Status; Endocrine System; Evaluation Studies as Topic; Family Planning Services; Fertility; Headache; Hemorrhage; Hormones; Incidence; Latin America; Levonorgestrel; Menstrual Cycle; Menstruation; Menstruation Disturbances; Neurologic Manifestations; Parity; Patient Acceptance of Health Care; Physiology; Population; Population Characteristics; Population Dynamics; Reproduction; Reproductive Control Agents; Research; Research Design; Sexual Behavior; Signs and Symptoms; South America; Statistics as Topic | 1984 |
Levonorgestrel-releasing intrauterine system for menstrual dysfunction: patient satisfaction in the district general hospital setting.
Topics: Adolescent; Adult; Female; Hospitals, District; Hospitals, General; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medical Audit; Medical Records; Menstruation Disturbances; Middle Aged; Patient Satisfaction; Retrospective Studies; Scotland; Surveys and Questionnaires | 2002 |
Characteristics of menstrual problems associated with Norplant discontinuation: results of a multinational study.
Topics: Adult; Africa; Asia; Counseling; Drug Implants; Female; Humans; Latin America; Levonorgestrel; Logistic Models; Menstruation Disturbances; Treatment Refusal | 2003 |
Update on treatment of menstrual disorders.
Topics: Adult; Contraceptive Agents, Female; Cost-Benefit Analysis; Embolization, Therapeutic; Female; Humans; Hysterectomy, Vaginal; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Middle Aged; Uterine Neoplasms | 2003 |
The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease.
Topics: Adult; Cohort Studies; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Palliative Care; Progestins; Severity of Illness Index; Treatment Outcome | 2004 |
Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Patient Satisfaction; Surveys and Questionnaires | 2004 |
Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.
Topics: Adult; Blood Vessels; Contraceptive Agents, Female; Endometrium; Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Progesterone; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factors | 2005 |
Evaluation of haemostatic function in Nigerian Norplant acceptors after 12 months of use.
Topics: Adult; Contraceptive Agents, Female; Erythrocyte Indices; Female; Hemostasis; Humans; Levonorgestrel; Longitudinal Studies; Menstruation Disturbances; Partial Thromboplastin Time; Platelet Count; Prospective Studies; Prothrombin Time | 2005 |
Cerazette for premenstrual tension.
Topics: Adult; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Menstruation Disturbances; Middle Aged; Premenstrual Syndrome | 2005 |
Minor error in our paper which was recently published in Contraception.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Medical Records; Menstrual Cycle; Menstruation Disturbances; Pregnancy; Uterine Hemorrhage | 2006 |
[Therapeutic trend in acne associated with the menstrual cycle].
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel | 1983 |
A two-year experience with Norplant implants in Assiut, Egypt.
Topics: Adult; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Implants; Egypt; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy; Pregnancy, Unwanted; Silicone Elastomers | 1984 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. I-Use effectiveness. An international comparative trial.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Leukorrhea; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy; Statistics as Topic; Vagina | 1981 |
Reduction of plasma high-density lipoprotein cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatment.
Topics: Cholesterol; Cholesterol, HDL; Female; Heparin; Humans; Levonorgestrel; Lipase; Lipoproteins, HDL; Liver; Menopause; Menstruation Disturbances; Middle Aged; Norgestrel; Stereoisomerism | 1981 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. III-Menstrual patterns. An international comparative trial.
Topics: Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Norgestrel; Vagina | 1981 |
A cohort study of Norplant implant: side-effects and acceptance.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Cohort Studies; Contraceptive Agents, Female; Drug Implants; Female; Humans; Indonesia; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Patient Satisfaction; Pregnancy; Pregnancy Rate; Risk Factors; Surveys and Questionnaires; Uterine Hemorrhage | 1995 |
Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.
Topics: Administration, Oral; Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Estradiol; Female; Humans; India; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1995 |
Implantable contraception.
Topics: Adolescent; Adult; Contraindications; Drug Implants; Drug Interactions; Female; Humans; Levonorgestrel; Menstruation Disturbances; Middle Aged; Ovarian Cysts; Pain; Pregnancy; Pregnancy, Ectopic | 1994 |
[Norplant and its side effects].
Topics: Adult; Affective Symptoms; Age Factors; Alopecia; Female; Follow-Up Studies; Headache; Humans; Levonorgestrel; Menstruation Disturbances; Patient Satisfaction; Product Surveillance, Postmarketing; Weight Gain | 1995 |
Removal rates of subdermal levonorgestrel implants.
Topics: Adolescent; Adult; Alopecia; Drug Implants; Female; Follow-Up Studies; Headache; Humans; Levonorgestrel; Menstruation Disturbances; Patient Acceptance of Health Care; Patient Dropouts; Pregnancy; Pregnancy, Unwanted; Sex Counseling | 1994 |
Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
Topics: Adult; Biopsy; Drug Implants; Endometrium; Estradiol; Female; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Levonorgestrel; Menstruation Disturbances; Middle Aged; Progesterone; Uterine Hemorrhage; von Willebrand Factor | 1994 |
Contraceptive implants.
Topics: Adolescent; Adult; Consumer Behavior; Consumer Product Safety; Contraceptive Agents; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Megestrol; Menstruation Disturbances; Norpregnadienes | 1994 |
[Norplant contraception at the Rabta Tunis maternity hospital].
Topics: Adolescent; Adult; Diabetes Mellitus; Drug Implants; Female; Heart Diseases; Humans; Hypertension; Levonorgestrel; Menstruation Disturbances; Pregnancy; Pregnancy Complications; Prospective Studies; Risk Factors; Tunisia | 1994 |
Norplant subdermal contraceptive system: experience in Taiwan.
Topics: Abortion, Induced; Chromosome Aberrations; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Pregnancy; Taiwan; Time Factors | 1996 |
Beliefs about Depo-Provera among three groups of contraceptors.
Topics: Adolescent; Adult; Community Health Services; Contraceptive Agents, Female; Contraceptives, Oral; Family Planning Services; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Satisfaction; Pregnancy; Risk Factors; Urban Population; Weight Gain | 1996 |
[Contraception with levonorgestrel subdermal implants. A Tunisian study].
Topics: Adult; Contraceptives, Oral, Hormonal; Drug Implants; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation Disturbances; Progesterone Congeners; Tunisia | 1996 |
Menstrual bleeding patterns in Norplant-2 implant users.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Uterine Hemorrhage | 1996 |
Five-year evaluation of safety, efficacy and acceptability of Norplant implants in Nepal.
Topics: Adolescent; Adult; Consumer Behavior; Contraceptive Agents, Female; Drug Implants; Evaluation Studies as Topic; Female; Humans; Levonorgestrel; Menstruation Disturbances; Nepal; Pregnancy; Surveys and Questionnaires | 1996 |
Risk factors for discontinuation of Norplant implant use due to menstrual problems.
Topics: Adult; Body Weight; Drug Implants; Educational Status; Female; Humans; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Pregnancy; Risk Factors; Smoking | 1996 |
Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use.
Topics: Adolescent; Case-Control Studies; Child; Condoms; Contraceptives, Oral; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation Disturbances; Pregnancy; Weight Gain | 1997 |
Menstrual disorders and progestin contraception. Proceedings of a meeting. Bali, Indonesia, 14-15 October 1995.
Topics: Animals; Contraceptive Agents, Female; Disease Models, Animal; Female; Humans; Levonorgestrel; Menstruation Disturbances; Progesterone Congeners; Uterine Hemorrhage | 1996 |
A comparison of the clinical performance, contraceptive efficacy, reversibility and acceptability of Norplant implants and Ortho Gynae T380 intrauterine copper contraceptive device.
Topics: Adult; Drug Implants; Female; Hemoglobins; Humans; Infertility, Female; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Pregnancy | 1997 |
[Norplant. Experiences at the maternity services of Orangers in Rabat during two years].
Topics: Adult; Contraceptive Agents, Female; Family Planning Services; Female; Hospitals, University; Humans; Levonorgestrel; Menstruation Disturbances; Patient Acceptance of Health Care; Prospective Studies | 1997 |
Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Topics: Adult; Amino Acid Sequence; Contraceptive Agents, Female; Endometrium; Estradiol; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Immunohistochemistry; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menstruation Disturbances; Middle Aged; Molecular Sequence Data; Peptide Fragments; Progesterone; Receptors, Estrogen; Receptors, Progesterone | 1998 |
Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
Topics: Adult; Contraceptive Agents, Female; Decidua; Endometrium; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunohistochemistry; Intrauterine Devices, Medicated; Leukocytes; Levonorgestrel; Longitudinal Studies; Menstruation Disturbances; Middle Aged; Receptors, Prolactin | 1998 |
[Evaluation of the pre-introduction of contraception by means of subcutaneous levonorgestrel implants in Burkina Faso].
Topics: Adult; Burkina Faso; Contraceptive Agents, Female; Drug Implants; Evaluation Studies as Topic; Female; Headache; Humans; Hypertension; Levonorgestrel; Marketing of Health Services; Mass Media; Menstruation Disturbances; Patient Acceptance of Health Care; Prospective Studies; Weight Gain | 1998 |
A 10-year follow-up study of contraceptive Norplant implants.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Device Removal; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation Disturbances | 2000 |
Norplant use among urban minority women in the United States.
Topics: Adult; Black or African American; Cohort Studies; Contraception; Contraceptive Agents, Female; Educational Status; Female; Gravidity; Hispanic or Latino; Humans; Levonorgestrel; Menstruation Disturbances; Minority Groups; Parity; Progesterone Congeners; Proportional Hazards Models; Prospective Studies; Survival Analysis; United States; Urban Population; Weight Gain; White People | 2000 |
Efficacy and side effects of immediate postcoital levonorgestrel used repeatedly for contraception. United Nations Development Programme/ United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Re
Topics: Adult; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Menstruation Disturbances; Pregnancy; Treatment Failure; Uterine Hemorrhage | 2000 |
Norplant: reasons for discontinuation and side-effects.
Topics: Activities of Daily Living; Adult; Contraceptives, Oral, Synthetic; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Pakistan; Patient Acceptance of Health Care; Retrospective Studies; Sexual Dysfunction, Physiological | 2000 |
Norplant users with irregular bleeding. Ultrasonographic assessment and evaluation of serum concentrations of estradiol and progesterone.
Topics: Adult; Contraceptive Agents, Female; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Progesterone; Ultrasonography; Uterine Hemorrhage | 2000 |
Levonorgestrel intrauterine device: new preparation. An alternative.
Topics: Clinical Trials as Topic; Contraceptive Agents, Female; Copper; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pregnancy; Pregnancy, Ectopic; Progesterone Congeners; Treatment Outcome | 1999 |
[Contraception using a subcutaneous implant, Norplant].
Topics: Adolescent; Adult; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Prospective Studies; Time Factors; Uterine Hemorrhage | 1992 |
Quantitation of hormone replacement induced withdrawal bleeds.
Topics: Adult; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Middle Aged; Norgestrel | 1991 |
The significance of bleeding patterns in Norplant implant users.
Topics: Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Norgestrel; Pregnancy; Time Factors | 1991 |
Effect of Norplant contraceptive use on hemoglobin, packed cell volume and menstrual bleeding patterns.
Topics: Adult; Blood Volume; Female; Follow-Up Studies; Hemoglobins; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Norgestrel | 1989 |
Menstrual changes associated with progestogen-only contraception.
Topics: Administration, Oral; Amenorrhea; Contraceptive Agents, Female; Counseling; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norgestrel; Time Factors | 1986 |
Chinical experience with levonorgestrel and ethinyl estradiol in Beijing.
Topics: Adult; China; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel | 1987 |
Five-year experience with Norplant implants in Assiut, Egypt.
Topics: Adult; Age Factors; Blood Pressure; Body Weight; Egypt; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Norgestrel; Patient Compliance; Pregnancy; Prostheses and Implants; Silicone Elastomers; Uterine Hemorrhage | 1987 |
[Evaluation of the contraceptive agent norplant in the municipality of Rio de Janeiro, RJ (Brazil)].
Topics: Administration, Oral; Adolescent; Adult; Blood Pressure; Body Weight; Evaluation Studies as Topic; Female; Humans; Hypertension; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Norgestrel; Parity; Product Surveillance, Postmarketing | 1987 |
Norplant-2 rods: one year experience in Singapore.
Topics: Adult; Arm; Consumer Behavior; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Singapore | 1988 |
A two-year study of acceptability, side effects, and effectiveness of Norplant and Norplant-2 implants in the People's Republic of China.
Topics: Adolescent; Adult; Cardiovascular System; China; Contraceptive Agents, Female; Drug Evaluation, Preclinical; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Platelet Count; Pregnancy | 1988 |
Phase III-clinical trial with Norplant-2 (covered rods). Report of a 24-month study. National Programme of Research in Human Reproduction. Division of Human Resource Development Research Indian Council of Medical Research Ansari Nagar, New Delhi, India.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy | 1988 |